News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
167,015 Results
Type
Article (31810)
Company Profile (12)
Press Release (135193)
Section
Business (52021)
Career Advice (365)
Deals (3228)
Drug Delivery (12)
Drug Development (23809)
Employer Resources (33)
FDA (3308)
Job Trends (3167)
News (80289)
Policy (4172)
Tag
Academia (2393)
Africa (261)
Alliances (10795)
Alzheimer's disease (436)
Antibody-drug conjugate (ADC) (10)
Approvals (3299)
Arizona (33)
Artificial intelligence (17)
Asia (10142)
Australia (2549)
Bankruptcy (18)
Best Places to Work (2596)
Breast cancer (10)
C2C Services and Suppliers (14814)
California (351)
Canada (162)
Cancer (72)
Career advice (337)
Cell therapy (22)
China (23)
Clinical research (17667)
Collaboration (19)
Colorado (22)
Connecticut (13)
COVID-19 (1150)
Cystic fibrosis (15)
Data (30)
Diabetes (12)
Diagnostics (1556)
Diversity, equity & inclusion (13)
Earnings (6013)
Employer resources (29)
Europe (26760)
Events (16768)
Executive appointments (52)
FDA (3335)
Florida (44)
Funding (14)
Gene therapy (17)
Georgia (12)
GLP-1 (107)
Government (933)
Healthcare (5047)
Hotbed/Location (99051)
Idaho (11)
Illinois (73)
Indiana (27)
Infectious disease (1154)
Inflammatory bowel disease (26)
Interviews (40)
IPO (1447)
Job creations (576)
Job search strategy (316)
Kansas (13)
Layoffs (27)
Legal (675)
Liver cancer (16)
Maine (10)
Maryland (40)
Massachusetts (186)
Medical device (2975)
Medtech (2975)
Mergers & acquisitions (1777)
Metabolic disorders (37)
Michigan (12)
Minnesota (32)
Neuroscience (461)
New Jersey (89)
New York (118)
NextGen Class of 2024 (1801)
Non-profit (1702)
North Carolina (162)
Northern California (200)
Obesity (18)
Ohio (35)
Opinion (26)
Pennsylvania (91)
People (31374)
Phase I (5622)
Phase II (8120)
Phase III (5341)
Pipeline (14)
Policy (12)
Postmarket research (955)
Preclinical (2984)
Press Release (25)
Rare diseases (20)
Real estate (1268)
Recruiting (16)
Regulatory (2755)
Research institute (1348)
Resumes & cover letters (24)
South America (288)
Southern California (141)
Startups (1109)
Texas (42)
United States (1499)
Vaccines (151)
Washington State (39)
Weight loss (15)
Date
Today (22)
Last 7 days (68)
Last 30 days (430)
Last 365 days (8252)
2024 (5052)
2023 (9291)
2022 (11522)
2021 (13265)
2020 (12811)
2019 (12201)
2018 (9054)
2017 (8718)
2016 (8910)
2015 (10235)
2014 (7801)
2013 (7581)
2012 (7550)
2011 (7566)
2010 (6771)
167,015 Results for "stanford university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
The Feinstein Institutes 2024 Ross Prize awarded to Stanford University’s Dr. Michelle Monje
The Feinstein Institutes for Medical Research has selected Michelle Monje, MD, PhD, from Stanford University, to receive the 11th annual Ross Prize in Molecular Medicine for her outstanding contributions to research relating to the neuroscience of cancer and its implications for therapy.
June 11, 2024
·
7 min read
Biotech Bay
Curiox Biosystems Announces the Establishment of the Curiox Innovation Center for the Curiox C-FREE™ Pluto LT System at Stanford University’s Human Immune Monitoring Center
Curiox Biosystems is pleased to announce the establishment of the Curiox Innovation Center for the Curiox C-FREE™ Pluto LT System at the Human Immune Monitoring Center (HIMC) at Stanford University.
June 25, 2024
·
2 min read
Press Releases
SOHM, Inc., Announce a New Collaboration and Joins Forces with Stanford University
July 25, 2024
·
3 min read
Drug Development
Secondary Cancer Risk Is Low After CAR T Cell Treatment: Stanford Study
Results of a large Stanford Medicine study, published Wednesday in The New England Journal of Medicine, finds CAR-T therapies carry a low risk of secondary malignancies not related to the T cells.
June 13, 2024
·
2 min read
·
Tristan Manalac
Drug Development
Kyverna Therapeutics and Stanford University Agree to Evaluate KYV-101 in Patients with Non-Relapsing and Progressive Forms of Multiple Sclerosis
Kyverna Therapeutics, Inc. announced the signature of a collaboration agreement with Stanford University to allow the use of KYV-101, an investigational, anti-CD19 CAR T-cell therapy in an open label, phase 1 investigator-initiated trial in nine to twelve adult subjects with non-relapsing and progressive forms of multiple sclerosis.
March 7, 2024
·
6 min read
Lone Star Bio
Fullpower®-AI Announces Groundbreaking Sleep Studies Presented at the SLEEP 2024 Conference in Partnership with Stanford Sleep Medicine and UCSF
Fullpower Technologies, in collaboration with Stanford Sleep Medicine and UCSF Department of Psychiatry and Behavioral Sciences, presented two major studies at the SLEEP 2024 conference, furthering our understanding of sleep fragmentation and heart rate variability (HRV) during sleep.
June 5, 2024
·
3 min read
Business
Novocure and Stanford School of Medicine to Establish Tumor Treating Fields Research Program
Novocure (NASDAQ: NVCR) today announced it has entered into an agreement with Stanford University to establish the Stanford School of Medicine Tumor Treating Fields (TTFields) Research Program.
October 12, 2023
·
5 min read
Biotech Bay
CERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing Attributes
CERo Therapeutics Holdings, Inc., announces it is presenting preclinical data on its lead product candidate CER-1236 at the Stanford Drug Discovery Symposium, which is being held April 29-30, 2024 in Palo Alto, Calif.
April 30, 2024
·
4 min read
Press Releases
aTyr Pharma Announces Research Study with Stanford Medicine
July 30, 2024
·
5 min read
Bio NC
Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024
Milestone® Pharmaceuticals Inc. announced upcoming data presentations on etripamil at ISPOR 2024 being held in Atlanta, GA on May 5-8, 2024, the 2024 Stanford BioDesign Arrhythmia Technologies Retreat in Boston, MA, on May 15, 2024, and the Annual meeting of the Heart Rhythm Society, Heart Rhythm 2024, in Boston, MA on May 16-19, 2024.
May 2, 2024
·
1 min read
1 of 16,702
Next
